TWST · Twist Bioscience Corp
United States · RS rating 87 · As of 2026-11-03
| Price | 140.30 USD |
|---|---|
| 1-day change | +8.7% |
| RS rating (overall / 1M / 3M / 12M) | 87 / 11 / 90 / 98 |
| Stage | Advancing |
| Composite / Minervini / CANSLIM score | 44 / 57 / 35 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -11.1% |
| Sales growth Q/Q | +4.7% |
| Distance from 52-week high | +31.6% |
| Market cap (USD) | $3.6B |